An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

John Dowd April is National Volunteer Month, and the Bitterroot is not short of volunteers that go above and beyond for the community. However, given that last month was […] ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

Dr. Alberto Ascherio of Harvard and Dr. Stephen Hauser of the University of California, San Francisco (UCSF) — will share $3 ...